Stocks · Health care · Biological Products, (No Diagnostic Substances)

Maze Therapeutics, Inc.

MAZE Clue Score57

United States Fiscal year ends December CIK 0001842295 Results filed 11 Aug 2026

Add to watchlist

What the insiders did Mostly scheduled

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$24.96M

$5.98M on a plan · $17.83M straight out of an exercise

Sold at will

$1.14M

16 of 100 sales

Net

−$24.96M

−$1.14M against sales at will